NewGenIvf Group Limited
NIVF · NASDAQ
12/31/2024 | 9/30/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $46,110 | $34,457 | $553,131 | $547,042 |
| - Cash | $458 | $170 | $54 | $39 |
| + Debt | $3,030 | $5,271 | $333 | $1,420 |
| Enterprise Value | $48,682 | $39,557 | $553,410 | $548,423 |
| Revenue | $1,274 | $1,473 | $1,519 | $0 |
| % Growth | -13.5% | -3.1% | – | – |
| Gross Profit | $359 | $646 | $197 | $0 |
| % Margin | 28.2% | 43.9% | 13% | – |
| EBITDA | $58 | $227 | $452 | $127 |
| % Margin | 4.6% | 15.4% | 29.7% | – |
| Net Income | -$108 | -$20 | -$955 | $127 |
| % Margin | -8.5% | -1.3% | -62.9% | – |
| EPS Diluted | -23.75 | -6.75 | 165.25 | 117.25 |
| % Growth | -251.9% | -104.1% | 40.9% | – |
| Operating Cash Flow | -$6,354 | – | -$143 | -$203 |
| Capital Expenditures | -$3 | – | -$0 | $0 |
| Free Cash Flow | -$6,357 | – | -$143 | -$203 |